Safety and tolerability of human mesenchymal stem cells for patients with decompensated cirrhosis

被引:0
|
作者
Fu, Qingchun
Wang, Xiaojin
Luo, Zhaoxia
Ni, Liuda
Li, Li
Chen, Jinjin
Zhou, Feng
Shi, Liqin
Jin, Yinpeng
Lv, Guangxiu
Hu, Xiang
Chen, Chengwei
机构
[1] Shanghai Liver Dis Res Ctr, Shanghai, Peoples R China
[2] Shenzhen Beike Cell Engn Res Inst, Shenzhen, Peoples R China
关键词
stem cell; adverse event; cirrhosis; safety;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:398 / 398
页数:1
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF HUMAN MESENCHYMAL STEM CELLS FOR PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A PRELIMINARY STUDY
    Fu, Q.
    Jiang, S.
    Wang, X.
    Luo, Z.
    Ni, L.
    Ye, S.
    Zhou, F.
    Shi, L.
    Chen, J.
    Lv, G.
    Wang, Z.
    Chen, C.
    Hu, X.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S35 - S36
  • [2] Decompensated Cirrhosis - Are mesenchymal Stem Cells a Therapeutic Option?
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 254 - 254
  • [3] Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients
    Zhang, Zheng
    Lin, Hu
    Shi, Ming
    Xu, Ruonan
    Fu, Junliang
    Lv, Jiyun
    Chen, Liming
    Lv, Sa
    Li, Yuanyuan
    Yu, Shuangjie
    Geng, Hua
    Jin, Lei
    Lau, George K. K.
    Wang, Fu-Sheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 112 - 120
  • [4] Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis
    Fernandez, Javier
    Nunez, Laura
    Costa, Montserrat
    Torres, Mireia
    Horrillo, Raquel
    Afonso, Natalia
    Mestre, Anna
    Del Arbol, Luis Ruiz
    Villanueva, Candid
    Paez, Antonio
    Arroyo, Vicente
    JOURNAL OF HEPATOLOGY, 2024, 80 : S231 - S231
  • [5] A case series on safety and tolerability of human umbilical cord-derived mesenchymal stem cells on patients in Malaysia
    Yusof, Basmullah
    Kamal, Iqmaliza
    Lee, Ka Man
    Chai, Siong Kiat
    Zuo, Xia Lin
    Ravichandran, Manickam
    Ding, Ke Xiang
    Fuloria, Neeraj Kumar
    Tham, Seng Kong
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [6] SAFETY OF USE OF COMBINATION OF AUTOLOGOUS MESENCHYMAL AND HEMATOPOIETIC STEM CELL INFUSION IN DECOMPENSATED CIRRHOSIS
    Sharma, Mithun
    Rao, Padaki Nagaraja
    Kulkarni, Anand
    Kumar, Pramod
    Jagtap, Nitin
    Gupta, Rajesh
    Singh, Jagdeesh Rampal
    Mitnala, Sasikala
    Nageshwar, Duvurr
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 55 - 55
  • [7] Immunomodulatory effect of bone marrow mesenchymal stem cells on T lymphocytes in patients with decompensated liver cirrhosis
    Guo, C. H.
    Han, L. X.
    Wan, M. R.
    Deng, G. J.
    Gan, J. H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 7039 - 7046
  • [8] Intraportal human hepatocytes transplantation combined with placental mesenchymal stem cells and systemic intravenous placental mesenchymal stem cells infusion in decompensated liver cirrhosis.
    Efimov, Denis
    Sadouski, Dzianis
    Primakova, Evgeniya
    Symanovich, Ala
    Korotkov, Sergey
    Yurkina, Ekaterina
    Shcherba, Aliaksei
    Krivenko, Svetlana
    Rummo, Oleg
    TRANSPLANTATION, 2024, 108 (9S)
  • [9] Intraportal human hepatocytes transplantation combined with placental mesenchymal stem cells and systemic intravenous placental mesenchymal stem cells infusion in decompensated liver cirrhosis.
    Efimov, Denis
    Sadouski, Dzianis
    Primakova, Evgeniya
    Symanovich, Ala
    Korotkov, Sergey
    Yurkina, Ekaterina
    Shcherba, Aliaksei
    Krivenko, Svetlana
    Rummo, Oleg
    TRANSPLANTATION, 2024, 108 (09) : 173 - 173
  • [10] Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
    Zepeng Li
    Xiaoling Zhou
    Lu Han
    Meijie Shi
    Huanming Xiao
    Ming Lin
    Xiaoling Chi
    Journal of Gastrointestinal Surgery, 2023, 27 : 926 - 931